Sort
21,281 grants matching “influenza”
Metabolic and Immune Responses to Flu Vaccine in Mitochondrial Disease Patients
$153,600Cornelia L Dekker · Stanford University · R21 · FY2011 · HD
Respiratory infections and vaccination behaviors in patients with chronic inflammatory skin diseases
$153,572Megan H Noe · Brigham And Women'S Hospital · K23 · FY2019 · AR
Immune Dysfunction in HIV + Opiod Users
$153,500Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2021 · DA
Immune Dysfunction in HIV + Opiod Users
$153,500Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2022 · DA
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens
$153,495Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination
$153,495Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes
$153,357Marian Patricia Jarlenski · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DA
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing
$153,336Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2010 · AI
Regulatory T cells in the influenza response of the aged
$153,238Phyllis-Jean Linton · San Diego State University · R21 · FY2009 · AG
4-Aminopiperidines as novel anti-influenza agents
$153,183Lijun Rong · Chicago Biosolutions, Inc. · R41 · FY2017 · AI
Respiratory infections and vaccination behaviors in patients with chronic inflammatory skin diseases
$153,172Megan H Noe · Brigham And Women'S Hospital · K23 · FY2020 · AR
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug Tourism
$153,045Steffanie A Strathdee · University Of California, San Diego · R01 · FY2020 · DA
Collaborative Research: RAPID: Wastewater Informed Epidemiological Monitoring of SARS-CoV-2
$153,027Kyle Bibby · University Of Notre Dame · · FY2020 · ENG
Alternative MHCII Processing of Influenza Virus Proteins
$152,912Laurence Crane Eisenlohr · Thomas Jefferson University · R01 · FY2015 · AI
Structure and functional dynamics of virus-host protein interactions
$152,849Jae Hyun Cho · Texas A&M Agrilife Research · R01 · FY2022 · GM
Respiratory infections and vaccination behaviors in patients with chronic inflammatory skin diseases
$152,760Megan H Noe · Brigham And Women'S Hospital · K23 · FY2021 · AR
CD4 T cell Immunity to Influenza
$152,668David Bram Lewis · Stanford University · U19 · FY2008 · AI
NK cell Immunity to Influenza
$152,668Peter R Parham · Stanford University · U19 · FY2008 · AI
Protective Mechanisms Against Pandemic Respiratory Virus (Resource D)
$152,668Elizabeth D Mellins · Stanford University · U19 · FY2008 · AI
Rapid, automated, detection of viral and bacterial pathogens causing meningitis
$152,630Andrew Hemmert · Biofire Defense, Llc. · R43 · FY2014 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$152,607Walter A. Orenstein · Emory University · N01 · FY2019 · AI
Comparative Effectiveness of Mitigation Strategies for Pandemic Influenza
$152,582Nayer Khazeni · Stanford University · K08 · FY2014 · HS
Development of the ferret model for EV-D68 infection
$152,496Joseph John Mattapallil · Henry M. Jackson Fdn For The Adv Mil/Med · R21 · FY2021 · AI
AVIAN INFLUENZA VIRUS (AIV) INFECTION IS A SERIOUS THREAT THAT CAN LEAD TO DRAMATIC LOSSES FOR THE POULTRY INDUSTRY AND IS A POTENTIAL HUMAN HEALTH RISK. AS DOMESTIC CHICKENS ARE HIGHLY SUSCEPTIBLE TO AIV, EVEN LOW PATHOGENICITY AIV (LPAIV) CAN CAUSE RESPIRATORY DISEASE AND REDUCE PERFORMANCE. BETTER UNDERSTANDING OF THE MECHANISMS BY WHICH THE CHICKEN'S INNATE IMMUNE SYSTEM RESPONDS TO AIV AND THEIR INVOLVEMENT IN HOST RESISTANCE ARE STILL NEEDED. THIS USDA-NIFA-AFRI-EWD POSTDOCTORAL FELLOWSHIP WILL INCREASE UNDERSTANDING OF RESISTANCE TO AIV INFECTION AND WILL FURTHER THE DEVELOPMENT OF AN INDEPENDENT RESEARCHER FOCUSED ON ANIMAL HEALTH AND GENOMICS. THIS PROJECT LEVERAGES WELL-CHARACTERIZED GENETIC LINES AND STATE-OF-THE-ART TECHNOLOGIES TO INVESTIGATE INNATE IMMUNE GENE EXPRESSION RESPONSES TO LPAIV AND TO IDENTIFY GENES AND PATHWAYS THAT CONTRIBUTE TO RESISTANCE TO INFECTION. WE WILL UTILIZE TWO INBRED CHICKEN LINES TO MODEL RESISTANCE AND SUSCEPTIBILITY, MEASURE GENOME-WIDEGENE EXPRESSION (THE TRANSCRIPTOME) AT THE RESOLUTION OF SINGLE CELLS, AND ASSAY SPECIFIC TARGET GENES (HIGH-THROUGHPUT QUANTITATIVE PCR) TO FURTHER COMPARE IN VIVO RESPONSES AND IN VITRO RESPONSES OF PRIMARY LUNG MACROPHAGES. THE IMMUNE RESPONSE MECHANISMS IDENTIFIED IN THIS PROJECT COULD BE USED TO EXAMINE HOST-PATHOGEN INTERACTIONS IN COMMERCIAL CHICKEN POPULATIONS, COULD INFORM RESEARCH ON GENETIC SELECTION OR IMPROVEMENT OF VACCINATIONS, AND IN THE LONG-TERM, COULD FACILITATE NEW STRATEGIES TO DECREASE THE NEGATIVE IMPACT OF AIV ON COMMERCIAL POULTRY.
$152,414Iowa State University Of Science And Technology · · FY2019 · National Institute of Food and Agriculture
Proteomics, Metabolomics and Lipidomics
$152,394Richard D Smith · University Of Wisconsin-Madison · U19 · FY2015 · AI